Fund Holdings — Lion Point Capital, LP

Total Portfolio Value
$24.93M
Total Bought
$3.20M
Total Sold
$10.39M
Net Transaction
-$7.19M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BIOHAVEN LTD(BHVN)035,400+35,40001,7697.10%+1,769
DISC MEDICINE INC(IRON)07,700+7,70003781.52%+378
BENITEC BIOPHARMA INC(BNTC)039,000+39,00003581.44%+358
ARCUTIS BIOTHERAPEUTICS INC(ARQT)035,100+35,10003261.31%+326
GERON CORP(GERN)630,000630,00002,6712,86011.47%+189
REGENXBIO INC(RGNX)36,25057,750+21,5004246062.43%+182
BLUEBIRD BIO INC678,2561,578,256+900,0006688203.29%+152
SERES THERAPEUTICS INC(MCRB)340,761340,76102473221.29%+76
FENNEC PHARMACEUTICALS INC(FENC)170,000215,000+45,0001,0391,0754.31%+36
MINERALYS THERAPEUTICS INC(MLYS)79,00079,00009249573.84%+32
BRIDGEBIO PHARMA INC(BBIO)49,00049,00001,2411,2485.00%+6
ALPHABET INC(GOOG)100100018170.07%-2
MICROSOFT CORP(MSFT)100100045430.17%-2
SPRUCE BIOSCIENCES INC75,00075,000039360.14%-3
BATTALION OIL CORP(BATL)7,4230-7,423250—-25
BURGERFI INTERNATIONAL INC2,083,4380-2,083,438260—-26
LUMOS PHARMA INC90,79439,589-51,2052111530.61%-57
JASPER THERAPEUTICS INC(JSPR)32,00032,00007266022.41%-124
AVADEL PHARMACEUTICALS PLC82,50064,000-18,5001,1608393.37%-321
KINIKSA PHARMACEUTICALS LTD(KNSA)104,69161,400-43,2911,9551,5346.16%-420
SYNDAX PHARMACEUTICALS INC(SNDX)65,00046,200-18,8001,3348893.57%-445
BURGERFI INTERNATIONAL INC2,745,9380-2,745,9385570—-557
MILESTONE PHARMACEUTICALS IN(MIST)2,340,2071,654,154-686,0533,0892,51410.09%-575
ENPHYS ACQUISITION CORP78,1250-78,1258580—-858
INSMED INC(INSM)70,33552,200-18,1354,7123,81115.29%-902
NEUROCRINE BIOSCIENCES INC(NBIX)8,3500-8,3501,1500—-1,150
MARINUS PHARMACEUTICALS INC2,114,827693,778-1,421,0492,4741,2214.90%-1,253
ARDELYX INC856,667370,000-486,6676,3482,54910.23%-3,799
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q3 2024 | TickerTrail